http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0050020-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ba2c4156354c844d4a8883be561f00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0a4798b6ef333502b27ef73ece9482d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
filingDate 2000-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de7867c5b9c5b9317eea0ed6dcc3178
publicationDate 2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0050020-A3
titleOfInvention Use of sulfamate derivatives for treating impulse control disorders
abstract Impulse Control Disorders (ICDs) are characterized by harmful behaviors performed in response to irresistible impulses. The essential feature of an ICD is the failure to resist an impulse, drive, or temptation and to perform an act that is harmful to the person or to others. The present invention comprises methods for the treatment or prevention of ICDs using a class of sulfamates of formula (I) wherein X is CH2 or oxygen, and R1, R2, R3, R4 and R5 are as herein defined. Further, pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention are also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125868-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107837-B2
priorityDate 1999-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800130-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4513006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0023059-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0007583-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0568306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0044374-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 41.